Thus, our comprehensive data illuminate that tumor-intrinsic FLI1 dampens T cell-mediated immunity by potentiating the IFN-γ-IDO1-Kyn pathway, thereby conferring a survival advantage to the tumor. Here, FLI1 is linked to neoplasm.